
|Articles|July 11, 2012
Drug Cost Control in Oncology
Panel members are asked to discuss what drives the cost of drugs in cancer care. They also discuss the role companion diagnostics and personalized medicine play in oncology.
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
USDA and HHS Update Dietary Guidelines to Encourage Real Food, Less Sugar
2
CDC Vaccine Rollback Highlights Gaps in Public Understanding of Shared Decision-Making
3
β-Blockers Show No Added Benefit After MI With Preserved LVEF
4
GLP-1s More Effective at Preventing Colorectal Cancer Than Aspirin
5




























































